Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo

Journal of Virology

Volumn 72, Issue 10, 1998, Pages 8257-8263

  Lubinski, John M ^a   Wang, Liyang ^a   Soulika, Athena M ^a   Burger, Reinhard ^b   Wetsel, Rick A ^c,d   Colten, Harvey ^c,e   Cohen, Gary H ^a   Eisenberg, Roselyn J ^a   Lambris, John D ^a   Friedman, Harvey M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b ROBERT KOCH INSTITUTE   (Germany)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; PROTEIN C;

ANTIGEN RECOGNITION; ARTICLE; COMPLEMENT FIXATION; GUINEA PIG; HERPES SIMPLEX VIRUS 1; IMMUNE RESPONSE; KNOCKOUT MOUSE; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; VAGINITIS; VIRULENCE; VIRUS TITRATION;

EID: 17644440172     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.10.8257-8263.1998     Document Type: Article

References (49)

1. Baucke, R. B., and P. G. Spear. 1979. Membrane proteins specified by herpes simplex viruses. V. Identification of an Fc-binding glycoprotein. J. Virol. 32:779-789.
2. Bergelson, J. M., M. Chan, K. R. Solomon, N. F. St. John, H. Lin, and R. W. Finberg. 1994. Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. Proc. Natl. Acad. Sci. USA 91:6245-6249.
3. Burger, R., J. Gordon, G. Stevenson, G. Ramadori, B. Zanker, U. Hadding, and D. Bitter-Suermann. 1986. An inherited deficiency of the third component of complement, C3, in guinea pigs. Eur. J. Immunol. 16:7-11.
4. Centifanto-Fitzgerald, Y. M., T. Yamaguchi, H. E. Kaufman, M. Tognon, and B. Roizman. 1982. Ocular disease pattern induced by herpes simplex virus is genetically determined by a specific region of viral DNA. J. Exp. Med. 155:475-489.
5. Chrisp, C. E., J. C. Sunstrum, D. R. Averill, Jr., M. Levine, and J. C. Glorioso. 1989. Characterization of encephalitis in adult mice induced by intracerebral inoculation of herpes simplex virus type 1 (KOS) and comparison with mutants showing decreased virulence. Lab. Investig. 60:822-830.
6. Cohen, G. H., M. Katze, C. Hydrean-Stern, and R. J. Eisenberg. 1978. Type common CP-1 antigen of herpes simplex virus is associated with a 59,000-molecular-weight envelope protein. J. Virol. 27:172-181.
7. Dix, R. D., R. R. McKendall, and J. R. Baringer. 1983. Comparative neurovirulence of herpes simplex virus type 1 strains after peripheral or intracerebral inoculation of BALB/c mice. Infect. Immun. 40:103-112.
8. Dubin, G., I. Frank, and H. M. Friedman. 1990. Herpes simplex virus type 1 encodes two Fc receptors which have different binding characteristics for monomeric immunoglobulin G (IgG) and IgG complexes. J. Virol. 64:2725-2731.
9. Dubin, G., E. Socolof, I. Frank, and H. M. Friedman. 1991. The herpes simplex virus Fc receptor protects infected cells from antibody-dependent cellular cytotoxicity. J. Virol. 65:7046-7050.
10. Eisenberg, R. J., M. P. de Leon, H. M. Friedman, L. F. Fries, M. M. Frank, J. C. Hastings, and G. H. Cohen. 1987. Complement component C3b binds directly to purified glycoprotein C of herpes simplex virus types 1 and 2. Microb. Pathog. 3:423-435.
11. Fingeroth, J. D., J. J. Weiss, T. F. Tedder, J. L. Strominger, P. A. Biro, and D. T. Fearon. 1984. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc. Natl. Acad. Sci. USA 81:4510-4514.
12. Fodor, W. L., S. A. Rollins, S. Bianco-Caron, R. P. Rother, E. R. Guilmette, W. V. Burton, J.-C. Albrecht, B. Fleckenstein, and S. P. Squinto. 1995. The complement control protein homolog of herpesvirus saimiri regulates serum complement by inhibiting C3 convertase activity. J. Virol. 69:3889-3892.
13. Frank, I., and H. M. Friedman. 1989. A novel function of the herpes simplex virus type 1 Fc receptor, participation in antibody bipolar bridging of antiviral immunoglobulin G. J. Virol. 63:4479-4488.
14. Friedman, H. M., G. H. Cohen, R. J. Eisenberg, C. A. Seidel, and D. B. Cines. 1984. Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells. Nature 309:633-635.
15. Friedman, H. M., J. C. Glorioso, G. H. Cohen, J. C. Hastings, S. L. Harris, and R. J. Eisenberg. 1986. Binding of complement component C3b to glycoprotein gC of herpes simplex virus type 1: mapping of gC-binding sites and demonstration of conserved C3b binding in low-passage clinical isolates. J. Virol. 60:470-475.
16. Friedman, H. M., L. Wang, N. O. Fishman, J. D. Lambris, R. J. Eisenberg, G. H. Cohen, and J. Lubinski. 1996. Immune evasion properties of herpes simplex virus type 1 glycoprotein gC. J. Virol. 70:4253-4260.
17. Fries, L. F., H. M. Friedman, G. H. Cohen, R. J. Eisenberg, C. H. Hammer, and M. M. Frank. 1986. Glycoprotein C of herpes simplex virus 1 is an inhibitor of the complement cascade. J. Immunol. 137:1636-1641.
18. Fruh, K., K. Ahn, H. Djaballah, P. Sempe, P. M. van Endert, R. Tampe, P. A. Peterson, and Y. Yang. 1995. A viral inhibitor of peptide transporters for antigen presentation. Nature 375:415-418.
19. Gerber, S. I., B. J. Belval, and B. C. Herold. 1995. Differences in the role of glycoprotein C of HSV-1 and HSV-2 in viral binding may contribute to serotype differences in cell tropism. Virology 214:29-39.
20. Griffiths, A., S. Renfrey, and T. Minson. 1998. Glycoprotein C-deficient mutants of two strains of herpes simplex virus type 1 exhibit unaltered adsorption characteristics on polarized or non-polarized cells. J. Gen. Virol. 79:807-812.
21. Harris, S. L., I. Frank, A. Yee, G. H. Cohen, R. J. Eisenberg, and H. M. Friedman. 1990. Glycoprotein C of herpes simplex virus type 1 prevents complement-mediated cell lysis and virus neutralization. J. Infect. Dis. 162: 331-337.
22. Hendricks, R. L., R. J. Epstein, and T. Tumpey. 1989. The effects of cellular immune tolerance to HSV-1 antigens on the immunopathology of HSV-1 keratitis. Investig. Ophthalmol. Visual Sci. 30:105-115.
23. Herold, B. C., D. WuDunn, N. Soltys, and P. G. Spear. 1991. Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J. Virol. 65:1090-1098.
24. Hidaka, Y., Y. Sakai, T. Yasushi, and R. Mori. 1991. Glycoprotein gC of herpes simplex virus type 1 is essential for the virus to evade antibody-independent complement-mediated virus inactivation and lysis of virus-infected cells. J. Gen. Virol. 72:915-921.
25. Hidaka, Y., S. Sakuma, Y. Kumano, H. Minagawa, and R. Mori. 1990. Characterization of glycoprotein C-negative mutants of herpes simplex virus type 1 isolated from a patient with keratitis. Arch. Virol. 113:195-207.
26. Hill, A., P. Jugovic, I. York, G. Russ, J. Bennick, J. Yewdell, H. Ploegh, and D. Johnson. 1995. Herpes simplex virus turns off the TAP to evade host immunity. Nature 375:411-415.
27. Huemer, H. P., C. Larcher, S. van Drunen Littel-van den Hurk, and L. A. Babiuk. 1993. Species selective interaction of Alphaherpesvirinae with the "unspecific" immune system of the host. Arch. Virol. 130:353-364.
28. Hung, S.-L., C. Peng, I. Kostavasili, H. M. Friedman, J. D. Lambris, R. J. Eisenberg, and G. H. Cohen. 1994. The interaction of glycoprotein C of herpes simplex virus types 1 and 2 with the alternative complement pathway. Virology 203:299-312.
29. Hung, S.-L., S. Srinivasan, H. M. Friedman, R. J. Eisenberg, and G. H. Cohen. 1992. Structural basis of C3b binding by glycoprotein C of herpes simplex virus. J. Virol. 66:4013-4027.
30. Isaacs, S. N., G. J. Kotwal, and B. Moss. 1992. Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence. Proc. Natl. Acad. Sci. USA 89:628-632.
31. Iwata, K., T. Seya, Y. Yanagi, J. M. Pesando, P. Johnson, M. Okabe, S. Ueda, H. Ariga, and S. Nagasawa. 1995. Diversity of sites for measles virus binding and for inactivation of complement C3b and C4b on membrane cofactor protein CD46. J. Biol. Chem. 270:15148-15152.
32. Johnson, D. C., M. C. Frame, M. W. Ligas, A. M. Cross, and N. D. Stow. 1988. Herpes simplex virus immunoglobulin G Fc receptor activity depends on a complex of two viral glycoproteins, gE and gI. J. Virol. 62:1347-1354.
33. Kostavasili, I., A. Sahu, H. M. Friedman, R. J. Eisenberg, G. H. Cohen, and J. D. Lambris. 1997. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus. J. Immunol. 158:1763-1771.
34. Lapin, L. 1975. Statistics, meaning and method. Harcourt Brace Jovanovich, Inc., New York, N.Y.
35. McFadden, G. 1995. Viroceptors, virokines and related immune modulators encoded by DNA viruses. R. G. Landes Co., Austin, Tex.
36. McNearney, T. A., C. Odell, V. M. Holers, P. G. Spear, and J. P. Atkinson. 1987. Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity. J. Exp. Med. 166:1525-1535.
37. Merriam, L. T., C. Webster, and R. J. Joehl. 1997. Complement component C5 deficiency reduces edema formation in murine ligation-induced acute pancreatitis. J. Surg. Res. 67:40-45.
38. Mold, C., B. M. Bradt, G. R. Nemerow, and N. R. Cooper. 1988. Epstein-Barr virus regulates activation and processing of the third component of complement. J. Exp. Med. 168:949-969.
39. Naganshumugam, T., J. Lubinski, L. Wang, L. T. Goldstein, B. S. Weeks, P. Sundaresan, E. H. Kang, G. Dubin, and H. M. Friedman. 1998. In vivo immune evasion mediated by herpes simplex virus type 1 immunoglobulin G Fc receptor. J. Virol. 72:5351-5359.
40. Rother, R. P., S. A. Rollins, W. L. Fodor, J.-C. Albrecht, E. Setter, B. Fleckenstein, and S. P. Squinto. 1994. Inhibition of complement-mediated cytolysis by the terminal complement inhibitor of herpesvirus saimiri. J. Virol. 68:730-737.
41. Sakai, Y., H. Minigawa, T. Ishibashi, H. Inomata, and R. Mori. 1994. Stromal keratitis induced by a unique clinical isolate of herpes simplex virus type 1. Ophthalmologica 208:157-160.
42. Sears, A. E., B. S. McGuire, and B. Roizman. 1991. Infection of polarized MDCK cells with herpes simplex virus 1: two asymmetrically distributed cell receptors interact with different viral proteins. Proc. Natl. Acad. Sci. USA 88:5087-5091.
43. Simmons, A., and A. A. Nash. 1984. Zosteriform spread of herpes simplex as a model of recrudescence and its use to investigate the role of immune cells in prevention of recurrent disease. J. Virol. 52:816-821.
44. Stanberry, L. R., E. R. Kern, J. T. Richards, T. M. Abbot, and J. C. Overall. 1982. Genital herpes in guinea pigs: pathogenesis of the primary infection and description of the recurrent disease. J. Infect. Dis. 146:397-404.
45. Sunstrum, J. C., C. E. Chrisp, M. Levine, and J. C. Glorioso. 1988. Pathogenicity of glycoprotein C negative mutants of herpes simplex virus type 1 for the mouse central nervous system. Virus Res. 11:17-32.
46. Tal-Singer, R., C. Peng, M. P. de Leon, W. R. Abrams, B. W. Banfield, F. Tufaro, G. H. Cohen, and R. J. Eisenberg. 1995. Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules. J. Virol. 69:4471-4483.
47. Tal-Singer, R., C. Seidel-Dugan, L. Fries, H. P. Huemer, R. J. Eisenberg, G. H. Cohen, and H. M. Friedman. 1991. Herpes simplex virus glycoprotein C is a receptor for complement component iC3b. J. Infect. Dis. 164:750-753.
48. Wetzel, R. Unpublished data.
49. WuDunn, D., and P. G. Spear. 1989. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J. Virol. 63:52-58.